Literature DB >> 16282594

Neuropeptide S and its receptor: a newly deorphanized G protein-coupled receptor system.

Rainer K Reinscheid1, Yan-Ling Xu.   

Abstract

Neuropeptide S (NPS) is a recently discovered bioactive peptide that has shed new light on the neurobiology of sleep/wakefulness regulation and anxiety-like behavior. NPS can potently promote arousal and suppress all stages of sleep. This effect might be modulated by NPS receptors expressed in thalamic centers that are relays for transmitting arousing stimuli originating from the brainstem to the cortex. The peptide precursor is expressed most prominently in a novel nucleus located directly adjacent to the noradrenergic locus coeruleus, a brain structure with well-defined functions in arousal, stress, and anxiety. NPS was also found to induce anxiolytic-like behavior in a battery of four different tests of innate responses to stress. This unique pharmacological profile of NPS offers significant potential for developing new drugs for the treatment of sleep and/or anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282594     DOI: 10.1177/1073858405276405

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  14 in total

1.  Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats.

Authors:  Michio Niimi
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

2.  Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala.

Authors:  Thomas Grund; Inga D Neumann
Journal:  Neuropsychopharmacology       Date:  2017-08-14       Impact factor: 7.853

Review 3.  Novel neuropeptides as ligands of orphan G protein-coupled receptors.

Authors:  Yan Zhang; Zhiwei Wang; Gregory Scott Parks; Olivier Civelli
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  Identification of neuropeptide S antagonists: structure-activity relationship studies, X-ray crystallography, and in vivo evaluation.

Authors:  Carla Hassler; Yanan Zhang; Brian Gilmour; Tyler Graf; Timothy Fennell; Rodney Snyder; Jeffrey R Deschamps; Rainer K Reinscheid; Celia Garau; Scott P Runyon
Journal:  ACS Chem Neurosci       Date:  2014-07-11       Impact factor: 4.418

5.  Central neuropeptide-S administration alleviates stress-induced impairment of gastric motor functions through orexin-A.

Authors:  Mehmet Bülbül; Osman Sinen; Onur Bayramoğlu
Journal:  Turk J Gastroenterol       Date:  2020-01       Impact factor: 1.852

6.  Escitalopram alters local expression of noncanonical stress-related neuropeptides in the rat brain via NPS receptor signaling.

Authors:  Aneta Piwowarczyk-Nowak; Artur Pałasz; Aleksandra Suszka-Świtek; Alessandra Della Vecchia; Aniela Grajoszek; Marek Krzystanek; John J Worthington
Journal:  Pharmacol Rep       Date:  2022-06-02       Impact factor: 3.919

Review 7.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

8.  A novel brain penetrant NPS receptor antagonist, NCGC00185684, blocks alcohol-induced ERK-phosphorylation in the central amygdala and decreases operant alcohol self-administration in rats.

Authors:  Annika Thorsell; Jenica D Tapocik; Ke Liu; Michelle Zook; Lauren Bell; Meghan Flanigan; Samarjit Patnaik; Juan Marugan; Ruslan Damadzic; Seameen J Dehdashti; Melanie L Schwandt; Noel Southall; Christopher P Austin; Robert Eskay; Roberto Ciccocioppo; Wei Zheng; Markus Heilig
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

9.  Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice.

Authors:  Covadonga Pañeda; Salvador Huitron-Resendiz; Laura M Frago; Julie A Chowen; Roberto Picetti; Luis de Lecea; Amanda J Roberts
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

10.  Constructing bioactive peptides with pH-dependent activities.

Authors:  Zhigang Tu; Melanie Volk; Khushali Shah; Kevin Clerkin; Jun F Liang
Journal:  Peptides       Date:  2009-05-21       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.